Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Clinical trials testing the drug on 300 obese patients in Australia once a day for 12 weeks tripled the weight loss compared to a placebo
Models of tendon injury, assessment of the proliferation and migration of tendon fibroblasts and activation of the FAK-paxillin pathway (Chang et al
This randomised, double-blind, placebo-controlled trial enrolled 706 adults with overweight or obesity (BMI 27 or above) across multiple dose groups, running over 26 weeks
Longevity: Results can be long-lasting, especially with proper sun protection
US$ 20.98
US$ 28.11
US$ 29.63
US$ 22.14
US$ 24.37
US$ 23.33
US$ 25.36
US$ 21.39
US$ 29.12
US$ 26.05
